Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Drug Dev Ind Pharm. 2016 Aug 21;43(5):789–796. doi: 10.1080/03639045.2016.1220567

Table 4.

Drug content analysis of F1 b (10% LNS- 30% F68- K12) and F2 (10% LNS- 4% MgO- 30% F68- K12) after 6 and 12 months of storage (25°C/60% RH).

Formulation Duration of the sorage (months) Drug content (%)
F1 b 6 96.21 ± 0.23
F1 b 12 96.91 ± 2.11
F2 6 98.83 ± 0.64
F2 12 99.12 ± 0.87

(mean ± SD, n = 3)